89 related articles for article (PubMed ID: 20436347)
21. Pathology and physiopathology of adenomyosis.
Bergeron C; Amant F; Ferenczy A
Best Pract Res Clin Obstet Gynaecol; 2006 Aug; 20(4):511-21. PubMed ID: 16563870
[TBL] [Abstract][Full Text] [Related]
22. Case of atypical polypoid adenomyoma that possibly underwent a serial progression from endometrial hyperplasia to carcinoma.
Fukuda M; Sakurai N; Yamamoto Y; Taoka H; Asakawa Y; Kurasaki A; Oharaseki T; Takahashi K; Kubushiro K
J Obstet Gynaecol Res; 2011 May; 37(5):468-71. PubMed ID: 21272150
[TBL] [Abstract][Full Text] [Related]
23. Effects of hormone therapy on the endometrium.
Deligdisch L
Mod Pathol; 1993 Jan; 6(1):94-106. PubMed ID: 8426860
[TBL] [Abstract][Full Text] [Related]
24. [Pulmonary densities following a hysterectomy, caused by benign metastatic leiomyoma].
Scheer ML; Slebos DJ; Bogchelman DH; Timens W
Ned Tijdschr Geneeskd; 2008 Sep; 152(37):2027-31. PubMed ID: 18825892
[TBL] [Abstract][Full Text] [Related]
25. Primary endometrial squamous cell carcinoma with extensive squamous metaplasia and dysplasia.
Bagga PK; Jaswal TS; Datta U; Mahajan NC
Indian J Pathol Microbiol; 2008; 51(2):267-8. PubMed ID: 18603705
[TBL] [Abstract][Full Text] [Related]
26. Concurrent endometrial carcinoma in women with a biopsy diagnosis of atypical endometrial hyperplasia: a Gynecologic Oncology Group study.
Trimble CL; Kauderer J; Zaino R; Silverberg S; Lim PC; Burke JJ; Alberts D; Curtin J
Cancer; 2006 Feb; 106(4):812-9. PubMed ID: 16400639
[TBL] [Abstract][Full Text] [Related]
27. [Clinical application of GnRHa before uterine myomectomy: report of 20 cases].
Yu YH; Gong SP; Wan SM
Di Yi Jun Yi Da Xue Xue Bao; 2004 Mar; 24(3):317-9. PubMed ID: 15041550
[TBL] [Abstract][Full Text] [Related]
28. Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate.
Palmara V; Triolo O; Benedetto V; Lo Re C; Sturlese E; Retto G; Santoro G
Gynecol Obstet Invest; 2010; 69(2):131-5. PubMed ID: 19996602
[TBL] [Abstract][Full Text] [Related]
29. [Endometrial hyperplasias: histology, classification, prognostic significance and therapy].
Horn LC; Bilek K; Schnurrbusch U
Zentralbl Gynakol; 1997; 119(6):251-9. PubMed ID: 9312959
[TBL] [Abstract][Full Text] [Related]
30. Complex papillary hyperplasia of the endometrium: an uncommon case report with cytopathological features and diagnostic implications.
Rekhi B; Menon S; Maheshwari A
Diagn Cytopathol; 2015 Feb; 43(2):163-8. PubMed ID: 24825243
[TBL] [Abstract][Full Text] [Related]
31. Use of a gonadotropin-releasing hormone agonist to manage perimenopausal women with symptomatic uterine myomas.
Wang PH; Lee WL; Cheng MH; Yen MS; Chao KC; Chao HT
Taiwan J Obstet Gynecol; 2009 Jun; 48(2):133-7. PubMed ID: 19574174
[TBL] [Abstract][Full Text] [Related]
32. [GnRH analogues and myomas: against but...].
Fernandez H
Gynecol Obstet Fertil; 2005 Dec; 33(12):1019-22. PubMed ID: 16314135
[No Abstract] [Full Text] [Related]
33. Hormonal therapy before surgical treatment for uterine leiomyomas.
Moghissi KS
Surg Gynecol Obstet; 1991 Jun; 172(6):497-502. PubMed ID: 1827931
[TBL] [Abstract][Full Text] [Related]
34. Effects of gonadotropin-releasing hormone agonists on uterine leiomyomas.
Cramer SF
Arch Pathol Lab Med; 1998 Dec; 122(12):1045-6. PubMed ID: 9870847
[No Abstract] [Full Text] [Related]
35. Hysteroscopic view in atypical endometrial hyperplasias: A correlation with pathologic findings on hysterectomy specimens.
Garuti G; Mirra M; Luerti M
J Minim Invasive Gynecol; 2006; 13(4):325-30. PubMed ID: 16825075
[TBL] [Abstract][Full Text] [Related]
36. Assessing endometrial hyperplasia and carcinoma treated with progestin therapy.
Mentrikoski MJ; Shah AA; Hanley KZ; Atkins KA
Am J Clin Pathol; 2012 Oct; 138(4):524-34. PubMed ID: 23010707
[TBL] [Abstract][Full Text] [Related]
37. Vaginal expulsion of a submucosal myoma during treatment with long-acting gonadotropin-releasing hormone agonist.
Wen L; Tseng JY; Wang PH
Taiwan J Obstet Gynecol; 2006 Jun; 45(2):173-5. PubMed ID: 17197363
[TBL] [Abstract][Full Text] [Related]
38. Endometrial Synovial-like Metaplasia Associated With Levonorgestrel-releasing Intrauterine System.
Stewart CJ; Leake R
Int J Gynecol Pathol; 2015 Nov; 34(6):570-5. PubMed ID: 26447355
[TBL] [Abstract][Full Text] [Related]
39. Gonadotropin-releasing hormone analogues inhibit leiomyoma extracellular matrix despite presence of gonadal hormones.
Malik M; Britten J; Cox J; Patel A; Catherino WH
Fertil Steril; 2016 Jan; 105(1):214-24. PubMed ID: 26409322
[TBL] [Abstract][Full Text] [Related]
40. Gonadotropin-releasing hormone (GnRH) agonist leuprolide acetate and GnRH antagonist cetrorelix acetate directly inhibit leiomyoma extracellular matrix production.
Britten JL; Malik M; Levy G; Mendoza M; Catherino WH
Fertil Steril; 2012 Nov; 98(5):1299-307. PubMed ID: 22901846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
